Could Single-Cell RNA Sequencing Help Personalize Multiple Myeloma Treatment?

December 30, 2017

This video highlights research that found that single-cell RNA sequencing can better characterize patients and potentially improve multiple myeloma treatment in a more personalized manner.

In this video, Samir Parekh, MD, of Icahn School of Medicine at Mount Sinai in New York, highlights a study that shows that patients with relapsed multiple myeloma may need highly individualized therapy to overcome the complexity of relapsed disease. The researchers found that single-cell RNA sequencing can better characterize patients and potentially improve treatment in a more personalized manner.

Results of the study (abstract 62) were presented at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.